SANUWAVE will hold a conference call on Wednesday, January 19, 2022, at 9am ET to discuss its recent business activity
SUWANEE, GA, Jan. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (SNWV), a leading provider of next-generation wound care products, announced it will hold a conference call on Wednesday, January 19, 2022, at 9:00 am ET to discuss its recent business activity, provide an update on SEC filings and detail strategic initiatives.
Telephone access to the live call will be available by dialing the following numbers:
Toll Free: 1-877-407-0784
A replay of the call can be accessed through February 2, 2022, at:
Toll Free: 1-844-512-2921
Replay Passcode: 13726404
About SANUWAVE Health
SANUWAVE Health (SNWV) is focused on the research, development, and commercialization of its patented, Energy First non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
SANUWAVE’s end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, plastic/cosmetic, and cardiac/endovascular conditions. For more information, please visit. www.SANUWAVE.com.
Investor Relations Contact
SANUWAVE Health, Inc.
Kevin Richardson II
Chairman and Chief Executive Officer